サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1760920

プロテオミクスの世界市場

Proteomics

出版日
ページ情報
英文 577 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.89円
プロテオミクスの世界市場
出版日: 2025年07月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 577 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

プロテオミクスの世界市場は2030年までに667億米ドルに到達

2024年に374億米ドルと推定されるプロテオミクスの世界市場は、分析期間2024-2030年にCAGR 10.1%で成長し、2030年には667億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである試薬は、CAGR 10.0％を記録し、分析期間終了時には492億米ドルに達すると予測されます。機器セグメントの成長率は、分析期間中CAGR 11.0%と推定されます。

米国市場は推定138億米ドル、中国はCAGR12.8%で成長予測

米国のプロテオミクス市場は2024年に138億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに65億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは12.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ9.0％と9.2％と予測されています。欧州では、ドイツがCAGR約9.7%で成長すると予測されています。

世界のプロテオミクス市場動向と促進要因まとめ

プロテオミクスは、タンパク質、その構造、機能、生物学的システム内での相互作用に関する大規模な研究です。タンパク質はほぼすべての細胞プロセスに不可欠であるため、プロテオミクスは細胞がどのように機能し、どのように病気が発症するかについての重要な洞察を提供します。プロテオミクスで使用される技術には、質量分析、タンパク質マイクロアレイ、タンパク質の同定と定量化、タンパク質修飾の解析、タンパク質間相互作用のマッピングを行う様々なバイオインフォマティクスツールが含まれます。これらの技術により、科学者はプロテオーム（生物、組織、細胞によって産生されるタンパク質全体）を探索することができます。異なる条件下でプロテオームを比較することにより、研究者は病気のバイオマーカーを特定し、病気のメカニズムを理解し、標的治療法を開発することができます。

最近のプロテオミクスの進歩は、その能力と応用を著しく向上させています。高分解能質量分析と高度なバイオインフォマティクスツールにより、タンパク質の同定と定量化の精度と効率が向上しました。次世代シーケンシングやCRISPR技術などの革新は、プロテオミクスとゲノミクスやトランスクリプトミクスとの統合を促進し、細胞プロセスのより包括的な理解を提供しています。さらに、シングルセルプロテオミクスの開発により、細胞の不均一性や疾患の進行をかつてない解像度で研究する新たな道が開かれつつあります。これらの技術の進歩は、プロテオームのより精密で詳細な解析を可能にするため、創薬、個別化医療、臨床診断など様々な分野でプロテオミクスの採用を促進しています。

プロテオミクス市場の成長は、いくつかの要因によって牽引されています。がんや心血管疾患などの慢性疾患の有病率の増加により、高度な診断・治療ソリューションに対する需要が高まり、プロテオミクスの採用に拍車がかかっています。また、個々のプロテオミクス・プロファイルを理解することで治療を調整する個別化医療へのシフトも大きな推進力となっています。成長を支える要因としては、多くの自己免疫疾患に対するタンパク質標的治療や精密分子医薬品の開発、質量分析ベースのプロテオミクスの開発、悪性腫瘍における分子標的の開発なども挙げられます。新しいプロテオミクスアプリケーションの特定、新薬の開発、心血管疾患やがんなどのさまざまな種類の疾患におけるプロテオミクスバイオマーカー探索のための研究開発におけるバイオテクノロジー企業や製薬企業の関心の高まりは、世界のプロテオミクス情勢における主要動向です。質量分析とバイオインフォマティクスの技術的進歩により、プロテオーム解析の機能が強化され、より利用しやすく費用対効果の高いものとなっています。さらに、バイオマーカー探索や医薬品開発などの分野での研究拡大が市場開拓に拍車をかけています。政府や非公開会社が研究やインフラストラクチャーに投資し、学術機関と製薬会社が協力していることも、市場の拡大に寄与しています。これらの要因に加えて、プロテオミクスがライフサイエンス研究の重要なツールとして認知されつつあることも、プロテオミクス市場の成長を後押ししています。

セグメント

コンポーネント（試薬、機器、サービス）;アプリケーション（創薬、疾病診断、その他のアプリケーション）

調査対象企業の例（注目の178社）

  • Active Motif, Inc.
  • 20/20 Genesystems, Inc.
  • BG Medicine, Inc.
  • BGI-Shenzhen
  • Biodesix, Inc.
  • Abbiotec LLC
  • BioChain Institute, Inc.
  • Arbor Vita Corporation
  • Biomosaics, Inc.
  • Advansta Inc.
  • AYOXXA Biosystems GmbH
  • AKESOgen, Inc.
  • Biognosys
  • Biorbyt
  • BioAnalyte

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • 中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-1029

Global Proteomics Market to Reach US$66.7 Billion by 2030

The global market for Proteomics estimated at US$37.4 Billion in the year 2024, is expected to reach US$66.7 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$49.2 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 11.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.8 Billion While China is Forecast to Grow at 12.8% CAGR

The Proteomics market in the U.S. is estimated at US$13.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.5 Billion by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.0% and 9.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.

Global Proteomics Market - Key Trends & Drivers Summarized

Proteomics is the large-scale study of proteins, their structures, functions, and interactions within a biological system. As proteins are essential to nearly every cellular process, proteomics provides crucial insights into how cells function and how diseases develop. Techniques used in proteomics include mass spectrometry, protein microarrays, and various bioinformatics tools to identify and quantify proteins, analyze protein modifications, and map protein-protein interactions. These techniques allow scientists to explore the proteome, the entire set of proteins produced by an organism, tissue, or cell. By comparing proteomes under different conditions, researchers can identify disease biomarkers, understand disease mechanisms, and develop targeted therapies, making proteomics indispensable in biomedical research.

Recent advancements in proteomics have significantly enhanced its capabilities and applications. High-resolution mass spectrometry and advanced bioinformatics tools have improved the accuracy and efficiency of protein identification and quantification. Innovations such as next-generation sequencing and CRISPR technology have facilitated the integration of proteomics with genomics and transcriptomics, providing a more comprehensive understanding of cellular processes. Additionally, the development of single-cell proteomics is opening new avenues for studying cellular heterogeneity and disease progression at an unprecedented resolution. These technological advancements are driving the adoption of proteomics in various fields, including drug discovery, personalized medicine, and clinical diagnostics, as they enable more precise and detailed analysis of the proteome.

The growth in the proteomics market is driven by several factors. The increasing prevalence of chronic diseases such as cancer and cardiovascular diseases has heightened the demand for advanced diagnostic and therapeutic solutions, spurring the adoption of proteomics. The shift towards personalized medicine, which relies on understanding individual proteomic profiles to tailor treatments, is also a significant driver. Factors supporting growth also include development of protein targeted treatments and precision molecular medicines for many autoimmune diseases, development of mass spectrometry-based proteomics, and development of molecular targets in malignancies. Increasing focus of biotechnological and pharmaceutical companies in research and development for identifying new proteomics applications, development of new drugs, and proteomics biomarker discovery in different types of diseases such as cardiovascular diseases and cancer is the major trend in the global proteomics landscape. Technological advancements in mass spectrometry and bioinformatics are enhancing the capabilities of proteomic analysis, making it more accessible and cost-effective. Furthermore, the expansion of research in areas such as biomarker discovery and drug development is fueling market growth. Government and private sector investments in proteomics research and infrastructure, coupled with collaborations between academic institutions and pharmaceutical companies, are also contributing to the market's expansion. These factors, along with the growing recognition of proteomics as a critical tool in life sciences research, are propelling the growth of the proteomics market.

SCOPE OF STUDY:

The report analyzes the Proteomics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Reagents, Instruments, Services); Application (Drug Discovery, Disease Diagnosis, Other Applications)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 178 Featured) -

  • Active Motif, Inc.
  • 20/20 Genesystems, Inc.
  • BG Medicine, Inc.
  • BGI-Shenzhen
  • Biodesix, Inc.
  • Abbiotec LLC
  • BioChain Institute, Inc.
  • Arbor Vita Corporation
  • Biomosaics, Inc.
  • Advansta Inc.
  • AYOXXA Biosystems GmbH
  • AKESOgen, Inc.
  • Biognosys
  • Biorbyt
  • BioAnalyte

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Proteomics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Proteins, Proteome and Proteomics: A Prelude
    • Genesis of Proteomics
    • Important Milestones
    • An Insight into Proteomics Data Type and their Characteristics / Features
    • Proteomics and Genomics: A Comparison
    • Applications of Proteomics
    • Outlook
    • Proteomics at the Fore with Latest Advances
    • Regional Analysis
    • Key Challenges to Address
    • Sparse and Difficult to Measure Data
    • Democratizing Proteomics
    • Absence of High-Profile Projects for Stimulating Interest
    • Creating Novel Experimental Design
    • Lack of Commercialization of High Throughput Impacts
    • Lack of Necessary Technical Skillset
    • Competition
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Proteomics Profiling to Expedite Drug Discovery
    • Other Applications of Proteomics in Drug Discovery
    • New Proteomics Technique to Aid Drug Screening & Biomarker Discovery
    • Growing Interest in Personalized Medicine to Drive Market Growth
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
    • Oncology: A Key Focus Area for Proteomics
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Proteomic Approaches Gain Prominence in Cancer Drug Discovery
    • Proteomics Technologies Used in Cancer Drug Discovery and Development
    • Role of Proteomics in Oncology Biomarker Discovery
    • List of FDA-approved Protein Biomarkers for Cancer
    • Advancements in Proteomics Bring Biomarkers into Limelight
    • Different Types of MS-Based Proteomic Discovery Techniques for Biomarkers
    • Affinity-Reagent-Array-Based Techniques
    • Affinity-and-Antibody-Based MS Techniques
    • CE-MS Technology: An Emerging Technology for Discovery of Biomarkers
    • Protein Microarrays: A Novel Tool for the Development of Pharmaceuticals
    • Protein Microarray Formats
    • New Technologies Expand Application of Proteomics
    • DIA Technique for Protein Discovery
    • AI and Machine Learning Address Shortcomings of Traditional Equipment in Effectively Identifying Protein Patterns
    • Bioinformatics Tools along with Proteomics Accelerate the Process of Pathway Prediction
    • Single-Cell Proteomics Offers a Better Understanding of Cellular Identity
    • Metalloproteomics: A Rapidly Evolving Field
    • Post-translational Modification of Proteins Increases Functional Diversity of Proteome
    • Pharmacoproteomics Holds Significant Prospects in Precision Medicine
    • Increasing Prominence of Nanoproteomics Widens Opportunities
    • Global Proteomics Sample Preparation Market
    • Challenges Faced
    • Management of Data in Proteomics Research Poses a Big challenge
    • Role of Contract Research Organizations to Increase in Proteomics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Disease Diagnosis by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Proteomics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Proteomics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Proteomics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Proteomics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 137: Middle East Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Middle East Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Middle East 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 140: Middle East Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Middle East Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Middle East 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 143: Africa Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Africa Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Africa 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 146: Africa Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Africa Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Africa 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION